Association of Mood and Anxiety Disorders and Opioid Prescription Patterns Among Postpartum Women.
Journal
The American journal on addictions
ISSN: 1521-0391
Titre abrégé: Am J Addict
Pays: England
ID NLM: 9208821
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
20
11
2019
revised:
24
02
2020
accepted:
20
03
2020
pubmed:
7
4
2020
medline:
30
4
2021
entrez:
7
4
2020
Statut:
ppublish
Résumé
Postpartum women represent a large population with opioid exposure who also have an increased risk of experiencing mood and anxiety disorders. However, the effect that mood and anxiety disorders have on opioid use postpartum has received little attention in the literature. Therefore, the objective of this study was to examine the association of mood and anxiety disorders with filling opioid prescriptions within the first 3 months postpartum. A retrospective cohort study (n = 25 279) was completed using claims data for a sample of privately insured women who gave birth in the state of Iowa. The interactive effects of mood and anxiety disorders and delivery mode on filling at least one and two or more opioid prescriptions were examined in logistic regression models. The presence of mood and anxiety disorders among women who delivered vaginally increased their odds of filling at least one opioid fill by nearly 50% (odds ratio [OR]: 1.48, 95% confidence interval [CI]: 1.35-1.63) and by 20% (OR: 1.20, 95% CI: 1.00-1.43) among women with cesarean delivery. Postpartum women with mood and anxiety disorders were more likely to fill opioid prescriptions postpartum compared to women without these conditions. This study extends prior research by examining the intersection of risk of mood and anxiety disorders and opioid use postpartum. Findings from this study support the need for future research to identify the drivers of increased opioid use among postpartum women with mood and anxiety disorders. (Am J Addict 2020;29:463-470).
Sections du résumé
BACKGROUND AND OBJECTIVES
Postpartum women represent a large population with opioid exposure who also have an increased risk of experiencing mood and anxiety disorders. However, the effect that mood and anxiety disorders have on opioid use postpartum has received little attention in the literature. Therefore, the objective of this study was to examine the association of mood and anxiety disorders with filling opioid prescriptions within the first 3 months postpartum.
METHODS
A retrospective cohort study (n = 25 279) was completed using claims data for a sample of privately insured women who gave birth in the state of Iowa. The interactive effects of mood and anxiety disorders and delivery mode on filling at least one and two or more opioid prescriptions were examined in logistic regression models.
RESULTS
The presence of mood and anxiety disorders among women who delivered vaginally increased their odds of filling at least one opioid fill by nearly 50% (odds ratio [OR]: 1.48, 95% confidence interval [CI]: 1.35-1.63) and by 20% (OR: 1.20, 95% CI: 1.00-1.43) among women with cesarean delivery.
DISCUSSION AND CONCLUSION
Postpartum women with mood and anxiety disorders were more likely to fill opioid prescriptions postpartum compared to women without these conditions.
SCIENTIFIC SIGNIFICANCE
This study extends prior research by examining the intersection of risk of mood and anxiety disorders and opioid use postpartum. Findings from this study support the need for future research to identify the drivers of increased opioid use among postpartum women with mood and anxiety disorders. (Am J Addict 2020;29:463-470).
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
463-470Informations de copyright
© 2020 American Academy of Addiction Psychiatry.
Références
Martin JA, Hamilton BE, Osterman MJ. Births in the United States, 2015. NCHS Data Brief. 2016:1-8.
Prabhu M, Garry EM, Hernandez-Diaz S, et al. Frequency of opioid dispensing after vaginal delivery. Obstet Gynecol. 2018;132:459-465.
Bateman BT, Cole NM, Maeda A, et al. Patterns of opioid prescription and use after cesarean delivery. Obstet Gynecol. 2017;130:29-35.
Dennis CL. Influence of depressive symptomatology on maternal health service utilization and general health. Arch Womens Ment Health. 2004;7:183-191.
Brummelte S, Galea LA. Postpartum depression: etiology, treatment and consequences for maternal care. Horm Behav. 2016;77:153-166.
Murray L, Cooper P, Fearon P. Parenting difficulties and postnatal depression: implications for primary healthcare assessment and intervention. Community Pract. 2014;87:34-38.
Mangla K, Hoffman MC, Trumpff C, et al. Maternal self-harm deaths: an unrecognized and preventable outcome. Am J Obstet Gynecol. 2019;221:295-303.
Volkow ND, Jones EB, Einstein EB, et al. Prevention and treatment of opioid misuse and addiction: a review. JAMA Psychiatry. 2019;76:208-216.
Bateman BT, Franklin JM, Bykov K, et al. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol. 2016;215:353.e351-353.e318.
O’Hara MW, Wisner KL. Perinatal mental illness: definition, description and aetiology. Best Pract Res Clin Obstet Gynaecol. 2014;28:3-12.
Letourneau NL, Dennis CL, Cosic N, et al. The effect of perinatal depression treatment for mothers on parenting and child development: a systematic review. Depress Anxiety. 2017;34:928-966.
Wisner KL, Parry BL, Piontek CM. Clinical practice. Postpartum depression. N Engl J Med. 2002;347:194-199.
Evans EC, Bullock LF. Optimism and other psychosocial influences on antenatal depression: a systematic review. Nurs Health Sci. 2012;14:352-361.
Madsen AM, Stark LM, Has P, et al. Opioid knowledge and prescribing practices among obstetrician-gynecologists. Obstet Gynecol. 2018;131:150-157.
Yonkers KA, Ramin SM, Rush AJ, et al. Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry. 2001;158:1856-1863.
Goodman JH, Watson GR, Stubbs B. Anxiety disorders in postpartum women: a systematic review and meta-analysis. J Affect Disord. 2016;203:292-331.
Services TCfMM. Chronic Conditions Data Warehouse. 2019. https://www.ccwdata.org/web/guest/condition-categories. Accessed January 3, 2019.
Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433-2445.
Becker NV, Gibbins KJ, Perrone J, et al. Geographic variation in postpartum prescription opioid use: opportunities to improve maternal safety. Drug Alcohol Depend. 2018;188:288-294.
Ailes EC, Dawson AL, Lind JN, et al. Opioid prescription claims among women of reproductive age-United States, 2008-2012. MMWR Morb Mortal Wkly Rep. 2015;64:37-41.
Osmundson SS, Schornack LA, Grasch JL, et al. Postdischarge opioid use after cesarean delivery. Obstet Gynecol. 2017;130:36-41.
Badreldin N, Grobman WA, Yee LM. Inpatient opioid use after vaginal delivery. Am J Obstet Gynecol. 2018;219:608.e601-608.e607.
Badreldin N, Grobman WA, Chang KT, et al. Patient and health care provider factors associated with prescription of opioids after delivery. Obstet Gynecol. 2018;132:929-936.
Mills JR, Huizinga MM, Robinson SB, et al. Draft opioid-prescribing guidelines for uncomplicated normal spontaneous vaginal birth. Obstet Gynecol. 2019;133:81-90.
Komatsu R, Carvalho B, Flood PD. Recovery after nulliparous birth: a detailed analysis of pain analgesia and recovery of function. Anesthesiology. 2017;127:684-694.
Badreldin N, Grobman WA, Chang KT, et al. Opioid prescribing patterns among postpartum women. Am J Obstet Gynecol. 2018;219:103.e101-103.e108.
Wilson MA, Junor L. The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models. Neuropsychopharmacology. 2008;33:2957-2968.
Eisenberger NI. The pain of social disconnection: examining the shared neural underpinnings of physical and social pain. Nat Rev Neurosci. 2012;13:421-434.
Eisenberger NI. Social pain and the brain: controversies, questions, and where to go from here. Annu Rev Psychol. 2015;66:601-629.
Grimes DA, Schulz KF. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol. 2012;120:920-927.
Holbrook A, Kaltenbach K. Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression. Am J Drug Alcohol Abuse. 2012;38:575-579.
Ehrenthal DB, Gelinas K, Paul DA, et al. Postpartum emergency department visits and inpatient readmissions in a medicaid population of mothers. J Womens Health (Larchmt). 2017;26:984-991.
Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findingsdepression screening in postpartum women. JAMA Psychiatry. 2013;70:490-498.